Patent details
EP4027983 Title: TREATMENT OF OCULAR NEOVASCULAR DISEASES USING AAV2 VARIANTS ENCODING AFLIBERCEPT
Basic Information
- Publication number:
- EP4027983
- PCT Application Number:
- US2020050079
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP207804675
- PCT Publication Number:
- WO2021050649
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- TREATMENT OF OCULAR NEOVASCULAR DISEASES USING AAV2 VARIANTS ENCODING AFLIBERCEPT
- French Title of Invention:
- TRAITEMENT DE MALADIES NÉOVASCULAIRES OCULAIRES À L'AIDE DE VARIANTS D'AAV2 CODANT POUR L'AFLIBERCEPT
- German Title of Invention:
- BEHANDLUNG VON NEOVASKULÄREN ERKRANKUNGEN UNTER VERWENDUNG VON AAV2-VARIANTEN, DIE FÜR AFLIBERCEPT KODIEREN
- SPC Number:
Dates
- Filing date:
- 10/09/2020
- Grant date:
- 19/11/2025
- EP Publication Date:
- 20/07/2022
- PCT Publication Date:
- 18/03/2021
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 19/11/2025
- EP B1 Publication Date:
- 19/11/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 10/09/2040
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 12/11/2025
- Name:
- Adverum Biotechnologies, Inc.
- Address:
- 100 Cardinal Way, Redwood City, CA 94063, United States (US)
Agent
- Name:
- NOVAGRAAF BREVETS
- From:
- 21/01/2026
- Address:
- BÂTIMENT O2, 2 RUE SARAH BERNHARDT CS90017, 92665, ASNIÈRES-SUR-SEINE cedex, France (FR)
- To:
Inventor
1
- Name:
- GASMI, Mehdi
- Address:
- United States (US)
2
- Name:
- KISS, Szilard
- Address:
- United States (US)
3
- Name:
- OSBORNE, Aaron
- Address:
- United States (US)
4
- Name:
- TURPCU, Adam
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201962899070 P
- Priority Date:
- 11/09/2019
- Priority Country:
- United States (US)
2
- Priority Number:
- 201962913648 P
- Priority Date:
- 10/10/2019
- Priority Country:
- United States (US)
3
- Priority Number:
- PCT/US2019/062066
- Priority Date:
- 18/11/2019
- Priority Country:
- World Intellectual Property Office (WIPO) (WO)
4
- Priority Number:
- 202062959784 P
- Priority Date:
- 10/01/2020
- Priority Country:
- United States (US)
5
- Priority Number:
- 202062971835 P
- Priority Date:
- 07/02/2020
- Priority Country:
- United States (US)
6
- Priority Number:
- 202063019190 P
- Priority Date:
- 01/05/2020
- Priority Country:
- United States (US)
7
- Priority Number:
- 202063030819 P
- Priority Date:
- 27/05/2020
- Priority Country:
- United States (US)
8
- Priority Number:
- 202063063203 P
- Priority Date:
- 07/08/2020
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/00; A61K 35/761; A61K 38/17; C12N 7/00; C12N 15/86; A61P 27/02;
Publication
European Patent Bulletin
- Issue number:
- 202547
- Publication date:
- 19/11/2025
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 30/09/2026
- Annual Fee Number:
- 7
- Annual Fee Amount:
- 82 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 21/01/2026 | Power Of Attorney | 1 |
| 22/01/2026 | Outgoing Correspondence | 1 |